Gayle A Crowell insider trades

Open-market stock purchases and sales by Gayle A Crowell, Director at Pliant Therapeutics, Inc, from SEC Form 4 filings since Nov 2, 2010.

Track record: 44% of 9 scored buys are up 5% or more since purchase, averaging +6%.

Recent trades

DateStockTradeValue
Jun 11, 2026PLRX Pliant Therapeutics, IncBought (not open market)—
Mar 26, 2026HTGC Hercules Capital, IncBought$105K
Feb 23, 2026HTGC Hercules Capital, IncBought$100K
Nov 3, 2025HTGC Hercules Capital, IncBought$107K

Companies traded

  • PLRX Pliant Therapeutics, Inc: other filings, last Jun 11, 2026
  • HTGC Hercules Capital, Inc: 8 buys, last Mar 26, 2026
  • ENV Envestnet, Inc: 1 buy, 19 sales, last Nov 25, 2024
  • YDLE Yodlee Inc: 7 sales, last Nov 19, 2015
  • SCIL Scientific Learning Corp: other filings, last May 20, 2012

Get free alerts when Gayle A Crowell files a new trade →